Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome ...
Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compo...
Singapore: Recruitment of patients for CAROLINA (cardiovascular outcome study of Linagliptin versus Glimepiride in patie...
Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerab...
Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...
Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commer...
Singapore: New Jersey's Charleston Laboratories Inc and Japanese major Daiichi Sankyo Inc have announced that the US Foo...
Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...
A finding, published in the Latin American Herald Tribune, says that a genetic study of people with Down's syndrome help...
Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...
Singapore: Novartis has proceeded to acquire all remaining rights of GSK's Ofatumumab, a fully human monoclonal antibo...
Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...
Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...
Singapore: Novartis has recieved USFDA approval for Promacta (eltrombopag) for the treatment of children six years and o...
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...
Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...
Singapore: AMRI has acquired all the outstanding shares of Spanish firm, Gadea Pharmaceutical Group, specializing in tec...
